Disease microbiology is a vast field of research, especially encompassing the recent and rapid advancements of omics science ...
Not so long ago, the omics field was a highly siloed collection of specialized applications and technologies. Now, multiomics is going mainstream. But as researchers revel in single cell resolution, ...
A recent study published in Engineering introduces GlycoPro, a novel high-throughput sample-processing platform that aims to transform the field of multi-glycosylation-omics analysis. Glycosylation, a ...
Since the advent of the Human Genome Project, scientists have expanded efforts to map complete biological datasets that encompass entire molecular families, such as DNA, RNA, proteins, and metabolites ...
A new computational tool helps researchers map molecular interactions, revealing the pathways associated with disease. Understanding how molecules interact inside our cells is key to uncovering how ...
Multi-omics describes the integration of multiple high-throughput screening technologies based on genomics, proteomics, transcriptomics, single-cell transcriptomics, metabolomics, and more, which all ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Ionpath, a leader in high-definition spatial proteomics, today announced the launch of MIBIslide™ Blue, a groundbreaking advancement in multimodal imaging.
“We believe OmicInsight’s best-in-market spatial omics imaging technology and its strategic pivot to translational research and AI platform will drive significant impact in the pharmaceutical industry ...
Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug ...
The magic cube shows that multi-omics (transcriptome, DNA methylome and chromatin accessibility) form a highly interlinked network and play important but different roles together in cardiac ...
A phase 1/2 study of FOG-001, a first-in-class direct β-catenin: TCF inhibitor, in patients with colorectal cancer (CRC) and other locally advanced or metastatic solid tumors. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results